In order to give full play to our technical superiority and make good use of existing resources, Professor Tang Shengbin has led our R&D personnel to carry out research on new projects of plant extracts since the beginning of this year, and has chosen to extract epimedium from epimedium and Rhodiola rosea. Ruthenium glycosides, rosaven and salidroside have made breakthroughs in the planting and purifying industry. A few days ago, breakthroughs have been made and various specifications of products have been produced to meet market demands. Due to the unique technology adopted by our company, the production cost is greatly reduced compared with that of the same industry while ensuring the product quality, which has won the first opportunity for our company to seize the extract market.
Copyright © 2021 Chongqing Taisun Pharmaceutical Co., Ltd. All rights reserved.